You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Muscular Dystrophy, Facioscapulohumeral

Showing 1 - 25 of 2,412
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FSHD Trial (MSOT Acuity Echo)

Not yet recruiting
  • FSHD
  • MSOT Acuity Echo
  • (no location specified)
Jun 5, 2023

FSHD, FSHD1, FSHD2 Trial (AOC 1020, Placebo)

Not yet recruiting
  • FSHD
  • +26 more
  • AOC 1020
  • Placebo
  • (no location specified)
Feb 27, 2023

Unraveling Metabolic Involvement in Facioscapulohumeral

Not yet recruiting
  • Facioscapulohumeral Muscular Dystrophy
  • metabolomic on plasma sample
  • (no location specified)
Oct 11, 2023

Facio-Scapulo-Humeral Dystrophy Trial (ARO-DUX4 for Injection, Placebo)

Not yet recruiting
  • Facio-Scapulo-Humeral Dystrophy
  • ARO-DUX4 for Injection
  • Placebo
  • (no location specified)
Nov 13, 2023

Facioscapulohumeral Muscular Dystrophy (FSHD) Trial (Placebo, RO7204239)

Recruiting
  • Facioscapulohumeral Muscular Dystrophy (FSHD)
  • København Ø, Denmark
    Rigshospitalet; Klinik for Nerve- og Muskelsygdomme
Feb 2, 2023

Type 1 Facioscapulohumeral Muscular Dystrophy Trial in Lille, Paris, Nice (Remote monitoring program)

Not yet recruiting
  • Type 1 Facioscapulohumeral Muscular Dystrophy
  • Remote monitoring program
  • Lille, Hauts De France, France
  • +2 more
Mar 31, 2023

FSHD Molecular Characterization

Recruiting
  • Facio-Scapulo-Humeral Dystrophy
    • Columbus, Ohio
      The Abigail Wexner Research Institute at Nationwide Children's H
    Oct 20, 2023

    Duchenne Muscular Dystrophy, Fascioscapulohumeral Muscular Dystrophy Trial in Liège (ActiMyo)

    Recruiting
    • Duchenne Muscular Dystrophy
    • Fascioscapulohumeral Muscular Dystrophy
    • ActiMyo
    • Liège, Belgium
      CHR de la Citadelle
    Aug 1, 2023

    FSHD1, FSHD2 Trial in Roma (Diaphragmatic ultrasound)

    Recruiting
    • FSHD1
    • FSHD2
    • Diaphragmatic ultrasound
    • Roma, Italy
      Fondazione Policlinico Gemelli IRCCS
    Oct 5, 2023

    The FBIndex - A Feasibility Study

    Not yet recruiting
    • Inclusion Body Myositis
    • +5 more
    • The risk of falls
    • (no location specified)
    May 26, 2023

    pwFSHD (Patient With Facioscapulohumeral Muscular Dystrophy)

    Completed
    • Facio-Scapulo-Humeral Dystrophy
      • Istanbul, Turkey
        Istanbul University-Cerrahpaşa
      Nov 7, 2022

      Facioscapulohumeral Muscular Dystrophy Type 2 Trial in France, Italy, Spain (Validation of new COMs for FSHD2 patients)

      Recruiting
      • Facioscapulohumeral Muscular Dystrophy Type 2
      • Validation of new COMs for FSHD2 patients
      • Nice, Alpes M, France
      • +5 more
      Oct 6, 2023

      Shoulder Instability in FSHD

      Completed
      • Shoulder Pain
      • +4 more
      • 3D movement analysis with surface electromyography and ultrasound
      • Oswestry, Gobowen, United Kingdom
        Robert Jones & Agnes Hunt Orthopaedic Hospital
      Jan 31, 2023

      Facioscapulohumeral Muscular Dystrophy Trial in Rochester (Testosterone Enanthate, Somatropin)

      Completed
      • Facioscapulohumeral Muscular Dystrophy
      • Rochester, New York
        University of Rochester
      Jun 7, 2022

      Facioscapulohumeral Muscular Dystrophy Trial in Nice (Validation of new COMs for non ambulant FSHD patients)

      Not yet recruiting
      • Facioscapulohumeral Muscular Dystrophy
      • Validation of new COMs for non ambulant FSHD patients
      • Nice, Alpes Maritimes, France
        CHU de Nice
      Jul 11, 2022

      Muscular Dystrophy, Facioscapulohumeral Trial in Leiden (CHDR Monitoring Remotely (MORE), Withings Steel HR, Withings Body+

      Completed
      • Muscular Dystrophy, Facioscapulohumeral
      • CHDR Monitoring Remotely (MORE)
      • +3 more
      • Leiden, Zuid Holland, Netherlands
        Centre for Human Drug Research
      Mar 8, 2022

      Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy

      Recruiting
      • Myotonic Dystrophy
      • +8 more
        • Rochester, New York
          University of Rochester Medical Center, Department of Neurology
        Jan 3, 2022

        A Registered Cohort Study on FSHD1

        Recruiting
        • Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
          • Fuzhou, Fujian, China
            First Affiliated Hospital of Fujian Medical University
          Jan 7, 2022

          Facioscapulohumeral Muscular Dystrophy (FSHD) Trial in Worldwide (Losmapimod, Placebo oral tablet)

          Recruiting
          • Facioscapulohumeral Muscular Dystrophy (FSHD)
          • Irvine, California
          • +31 more
          Jul 28, 2022

          Facioscapulohumeral Muscular Dystrophy (FSHD) Trial in Worldwide (Losmapimod, Placebo oral tablet)

          Completed
          • Facioscapulohumeral Muscular Dystrophy (FSHD)
          • Irvine, California
          • +16 more
          Feb 8, 2022

          Facioscapulohumeral Muscular Dystrophy, Charcot-Marie-Tooth Disease Trial in Canada, Spain, United States (ACE-083)

          Terminated
          Has Results
          • Facioscapulohumeral Muscular Dystrophy
          • Charcot-Marie-Tooth Disease
          • Orange, California
          • +23 more
          Sep 13, 2022

          Biomarker Development for Muscular Dystrophies

          Recruiting
          • Myotonic Dystrophy
          • +3 more
            • Boston, Massachusetts
            • +4 more
            Aug 20, 2021

            Readiness to Solve Barriers to Drug Development in FSHD

            Active, not recruiting
            • Facioscapulohumeral Muscular Dystrophy
            • FSHD-specific functional rating scale
            • Electrical Impedance Myography
            • Los Angeles, California
            • +7 more
            Sep 27, 2021

            Facioscapulohumeral Muscular Dystrophy (FSHD) Trial in Worldwide (Placebo, ATYR1940)

            Completed
            Has Results
            • Facioscapulohumeral Muscular Dystrophy (FSHD)
            • Placebo
            • ATYR1940
            • Rochester, New York
            • +4 more
            Jul 19, 2021

            Facioscapulohumeral Muscular Dystrophy Trial in Newcastle Upon Tyne (Patient Registry)

            Unknown status
            • Facioscapulohumeral Muscular Dystrophy
            • Patient Registry
            • Newcastle Upon Tyne, United Kingdom
              John Walton Muscular Dystrophy Research Centre
            Jan 7, 2021